ARTICLE | Clinical News
PRO 2000: PRCT started a Phase I/II dose-escalation trial in Belgium to evaluate safety and efficacy of PRO 2000.
May 20, 1996 7:00 AM UTC
Procept Inc. (PRCT), Cambridge, Mass. Product: PRO 2000, synthetic molecule derived from naphthalene sulfate Indication: HIV Status: PRCT started a Phase I/II dose-escalation trial in Belgium to eval...